- Q1 2024 Capricor Therapeutics Inc Earnings Call TranscriptMay 13, 2024$5.44 (+2.64%)Earnings
- Q4 2023 Capricor Therapeutics Inc Earnings Call TranscriptFeb 29, 2024$4.2 (-3.00%)Earnings
- Capricor Therapeutics Inc Phase 3 Hope 3 Program Update TranscriptSep 29, 2023
- Q2 2023 Capricor Therapeutics Inc Earnings Call TranscriptAug 07, 2023$4.71 (+3.06%)Earnings
- Q1 2023 Capricor Therapeutics Inc Earnings Call TranscriptMay 11, 2023$4.11 (+0.74%)Earnings
- Q4 2022 Capricor Therapeutics Inc Earnings Call TranscriptMar 15, 2023$4.47 (-3.66%)Earnings
- Capricor Therapeutics Inc To Present 18-Month Data Results From Ongoing HOPE-2 Open Label Extension TranscriptJan 25, 2023
- Q3 2022 Capricor Therapeutics Inc Earnings Call TranscriptNov 10, 2022$4.9 (+4.03%)Earnings
- Capricor Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Q2 2022 Capricor Therapeutics Inc Earnings Call TranscriptAug 10, 2022$4.52 (-1.95%)Earnings
- Capricor Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptMay 25, 2022
- Q1 2022 Capricor Therapeutics Inc Earnings Call TranscriptMay 10, 2022$3.24 (+3.69%)Earnings
- Q4 2021 Capricor Therapeutics Inc Earnings & Recent Corporate Update Call TranscriptMar 10, 2022
- Capricor Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 Capricor Therapeutics Inc Earnings Call TranscriptAug 12, 2021$4.48 (+1.59%)Earnings
- Q1 2021 Capricor Therapeutics Inc Earnings Call TranscriptMay 13, 2021$3.16 (-6.78%)Earnings
- Q4 2020 Capricor Therapeutics Inc Earnings Call TranscriptMar 11, 2021$5.54 (+1.84%)Earnings
- Q3 2020 Capricor Therapeutics Inc Earnings Call TranscriptNov 12, 2020$4.65 (-0.85%)Earnings
- Capricor Therapeutics Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 12, 2020
- Capricor Therapeutics Inc Overview of CAP-1002 in Patients with Duchenne Muscular Dystrophy TranscriptSep 02, 2020
- Q2 2020 Capricor Therapeutics Inc Earnings Call TranscriptAug 06, 2020$7.9 (-3.66%)Earnings
- Q1 2020 Capricor Therapeutics Inc Earnings Call TranscriptMay 14, 2020$6.55 (-1.65%)Earnings
- Capricor Therapeutics Inc to Discuss the Top-Line Results of the HOPE-2 Study - Call TranscriptMay 13, 2020
- Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call on CAP-1002 TranscriptApr 15, 2020
- Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call TranscriptMar 26, 2020
- Q4 2019 Capricor Therapeutics Inc Earnings Call TranscriptMar 18, 2020$1.12 (-4.27%)Earnings
Capricor Therapeutics Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) Transcript
¡ -
Good afternoon. My name is Linda Marbán, and I am the CEO of Capricor Therapeutics. I want to thank the Alliance for Regenerative Medicine and the Meeting on the Mesa for hosting us today so that we can share with you the progress that we've made over the past year. This is a standard forward-looking statement slide. We are publicly traded, Nasdaq-listed under the symbol CAPR, and all of our filings are available on the SEC website.
So, I like to think of this slide sort of as the table of contents of what we're going to be discussing today. We're going to be talking about the two major product platforms that we have in our pipeline, our cell therapy product made from an allogeneic cell called CAP-1002, and our very exciting new exosome platform development program, which is going to be featuring engineered exosomes as well as exosomes made by our cells, the CDCs.
We have a strong balance sheet at this time with around $36 million in the bank. We have a long list of collaborators.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)